Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

A Simple Allergist-Led Intervention Improves Resident Training in Anaphylaxis.

Jongco AM, Bina S, Sporter RJ, Cavuoto Petrizzo MA, Kaplan B, Kline M, Schuval SJ.

J Allergy (Cairo). 2016;2016:9040319. doi: 10.1155/2016/9040319.

2.

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.

Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams..

Vaccine. 2013 Oct 1;31(42):4782-90. doi: 10.1016/j.vaccine.2013.08.002.

3.

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Qin M, Levin MJ, Fenton T, Beeler JA, Bellini WJ, Audet S, Sowers SB, Borkowsky W, Nachman SA, Pelton SI, Rosenblatt HM; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams..

J Infect Dis. 2012 Aug 15;206(4):512-22. doi: 10.1093/infdis/jis386.

4.

Conservative long-term treatment of children with eosinophilic esophagitis.

Levine J, Lai J, Edelman M, Schuval SJ.

Ann Allergy Asthma Immunol. 2012 May;108(5):363-6. doi: 10.1016/j.anai.2012.02.024.

PMID:
22541409
5.

Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.

Malee K, Williams P, Montepiedra G, McCabe M, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team..

AIDS Patient Care STDS. 2011 Mar;25(3):191-200. doi: 10.1089/apc.2010.0181.

6.

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team..

Pediatrics. 2010 Feb;125(2):e250-60. doi: 10.1542/peds.2009-1112.

7.

The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.

Kapetanovic S, Aaron L, Montepiedra G, Sirois PA, Oleske JM, Malee K, Pearson DA, Nichols SL, Garvie PA, Farley J, Nozyce ML, Mintz M, Williams PL; Pediatric AIDS Clinical Trials..

AIDS Patient Care STDS. 2009 Nov;23(11):939-47. doi: 10.1089/apc.2009.0121.

8.

Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.

Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie PA, Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell WG, Oleske JM; IMPAACT/PACTG 219C Team..

J Dev Behav Pediatr. 2009 Oct;30(5):403-12.

9.

Pharmacotherapy of pediatric and adolescent HIV infection.

Schuval SJ.

Ther Clin Risk Manag. 2009 Jun;5(3):469-84.

10.

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.

Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team..

AIDS. 2009 Sep 10;23(14):1893-901. doi: 10.1097/QAD.0b013e32832dc041.

11.

Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.

Van Dyke RB, Wang L, Williams PL; Pediatric AIDS Clinical Trials Group 219C Team..

J Infect Dis. 2008 Dec 1;198(11):1599-608. doi: 10.1086/593022.

12.

The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Malee K, Williams PL, Montepiedra G, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team..

J Pediatr Psychol. 2009 Mar;34(2):164-75. doi: 10.1093/jpepsy/jsn068.

13.

Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.

Patel K, HernĂ¡n MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team..

Clin Infect Dis. 2008 Jun 1;46(11):1751-60. doi: 10.1086/587900.

14.

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team..

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16.

15.

Interleukin 7 receptor alpha-chain-mutation severe combined immunodeficiency without lymphopenia: correction with haploidentical T-cell-depleted bone marrow transplantation.

Ponda P, Schuval SJ, Kaplan B, Logalbo P, Roberts JL, Bonagura VR.

Ann Allergy Asthma Immunol. 2006 Dec;97(6):755-8.

PMID:
17201233
16.

A 12-year-old girl with asthma, pneumonia, and pneumatoceles.

Tahzib MN, Schuval SJ.

Ann Allergy Asthma Immunol. 2003 May;90(5):480-4. No abstract available.

PMID:
12775128
17.

Treatment of antibody deficiency syndromes.

Schuval SJ.

Pediatr Rev. 2000 Oct;21(10):358-9. Review. No abstract available.

PMID:
11010985
18.

Increased frequency of HLA-DR11 in pediatric human immunodeficiency virus-associated parotid gland enlargement.

Schuval SJ, O'Reilly ME, Bonagura VR.

Clin Diagn Lab Immunol. 1997 May;4(3):258-60.

19.

Eczema and thrombocytopenia in an 8-month-old infant boy.

Weiss SJ, Schuval SJ, Bonagura VR.

Ann Allergy Asthma Immunol. 1997 Feb;78(2):179-82. No abstract available.

PMID:
9048525
20.

Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV-infected children.

Schuval SJ, Bonagura VR.

Arch Pediatr Adolesc Med. 1994 Aug;148(8):876-9. No abstract available.

PMID:
8044270

Supplemental Content

Loading ...
Support Center